MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/15/2026, 11:08 AM (Berlin time), refresh in progress.

Owlet Stock

Owlet, Inc.

OWLTNYSEMarkt
US$4.41
-4.8% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
United States
CEO
Kurt Workman
Employees
111
Market cap
$129 M
IPO
05/11/2020

Owlet, Inc. is a U.S.-based company that provides a digital platform specifically designed to support parents. Its primary objective is to equip families with immediate, valuable data and insights concerning their children. The company's product portfolio includes the Smart Sock, an advanced infant monitor that…

Owlet stock: price history

14/10/25-50.6 %14/10/26

1D

-4.8%

1W

-6.8%

1M

-6.6%

6M

-22.1%

YTD

-72.8%

1Y

-50.6%

2Y

+0.5%

5Y

-91.8%

10Y

–

Next earnings date

Next earnings date

12/11/2026 (in 26 days)

Volatility around earnings

~47% stronger price swings than usual

Ask the agents about Owlet

Analyst assessment of Owlet

PRICE TARGET LOW

US$20.00

CONSENSUS

US$108.00

MEDIAN

US$108.00

PRICE TARGET HIGH

US$196.00

0

STRONG BUY

4

BUY

2

HOLD

0

SELL

0

STRONG SELL

6

TOTAL · Buy

As of: 22/06/2026

ANALYST FIRMRATINGACTIONDATE
TD CowenBuymaintain22/06/2026
Northland Capital MarketsOutperformmaintain30/12/2025
Freedom BrokerBuymaintain20/11/2025
CitigroupNeutralmaintain16/11/2022 (older than 12 months)
Cowen & Co.Outperformmaintain20/10/2022 (older than 12 months)
B of A SecuritiesNeutralmaintain30/09/2022 (older than 12 months)
CitigroupNeutralmaintain12/05/2022 (older than 12 months)
CitigroupNeutralmaintain06/10/2021 (older than 12 months)

Owlet stock metrics

P/E

-10.26

P/B

3.23

EV/EBITDA

-18.62

RETURN ON EQUITY

-1.5%

NET MARGIN

-1.8%

DEBT/EQUITY

0.09

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

54.1%

FLOAT SHARES

15,797,193

AVG. DAILY VOLUME (30D)

170,377

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Workman Kurt

OfficerTax settlement20,4004.89Spontaneous08/10/2026

BURKE ZANE M

DirectorGrant18,996–Spontaneous21/08/2026

Stoll Marc F

DirectorGrant26,785–Spontaneous21/08/2026

Stoll Marc F

DirectorGrant18,996–Spontaneous21/08/2026

BURKE ZANE M

DirectorGrant26,785–Spontaneous21/08/2026
Page 1 / 7

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
ECLIPSE VENTURES, LLC7,700,835+030/06/2026
Granahan Investment Management, LLC1,595,419+408,76430/06/2026
CANNELL CAPITAL LLC1,234,053+235,88830/06/2026
AWM Investment Company, Inc.1,225,353-753,11730/06/2026
VANGUARD CAPITAL MANAGEMENT LLC801,718+20,19730/06/2026
Page 1 / 3

Dividends & Stock splits

DATERATIO
10/07/20231:14

Comparable stocks

Frequently asked questions about Owlet stock

What does Owlet do?

Owlet, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.

The CEO is Kurt Workman, the company employs around 111 people.

The IPO was on 05/11/2020; the stock trades on NYSE under the ticker OWLT.

What do analysts say about Owlet stock?

6 analysts rate the stock, the consensus is Buy (as of 22/06/2026).

The average price target is US$108.00, ranging from US$20.00 to US$196.00, with a median of US$108.00.

This is an external assessment, not a statement by Market Jury.

When does Owlet report next?

The next earnings date is 12/11/2026.

Around past earnings, price swings were roughly 47% stronger than usual.

Does Owlet pay a dividend?

No, Owlet currently does not pay a dividend.

Which stocks are comparable to Owlet?

Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.

How can I get Owlet stock analyzed?

Clicking "Analyze stock" lets five strategies assess Owlet against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.